– Patent-Pending Technologies Designed to Intercept and Destroy 99.9%+ of Airborne Pathogens Including SARS-CoV-2 and its Variants –
nUVo™ TRAVELER Now Available for Immediate Sale and nUVo™ TOWER for Pre-Order
Energy Focus, Inc. (NASDAQ: EFOI), a leader in sustainable and human-centric lighting (“HCL”) technologies, is now selling its nUVo™ TRAVELER for immediate delivery and taking pre-orders on nUVo™ TOWER for expected for delivery in early January 2022. Both Virus-Targeted UVC Air Disinfectors are available for order through Energy Focus distributors as well as directly on nUVo.us. nUVo™ Traveler is also immediately available to purchase for FirstEnergy Home customers at firstenergyhome.com.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211208005120/en/
nUVo™ TRAVELER Personal Virus-Targeted UVC Air Disinfector (Photo: Business Wire).
nUVo™ by Energy Focus UVC air disinfectors are designed to destroy 99.9%+ of airborne pathogens such as molds, bacteria, and viruses, including coronavirus and its variants, with one pass over their UVC lamps, by applying the proven disinfecting power of UVC-254nm light to break the DNA and RNA strands of pathogens. The nUVo air disinfectors also incorporate patent-pending UVC blockers to safely enclose the powerful UVC lamps while maximizing airflow.
More and more scientific studies have shown that SARS-CoV-2 viruses transmit largely through aerosols. nUVo™ is designed to create personal and portable comfort zones and make life safer for people and those around them by intercepting and destroying airborne pathogens in real time. Both nUVo TRAVELER and TOWER have been independently validated by Intertek Microbiological Tests for reducing between 94.1-99.9% of various pathogens within half an hour in realistically sized spaces – 100 cubic feet and 1,000 cubic feet, respectively.
Through effective and constant air disinfection, nUVo™ TRAVELER and nUVo™ TOWER promote health, safety, comfort, productivity, and peace-of-mind in personal and public spaces of all kinds, such as cars, homes, and offices. nUVo™ disinfectors are also filter-free and chemical-free. So unlike typical air purifiers, nUVo™ disinfectors eliminate costly and time-consuming filter replacements and do not leave potentially harmful and pungent chemical residues. The safely enclosed, replaceable UVC lamps will last approximately 3 years if used 8 hours per day.
- nUVo™ TRAVELER Virus-Targeted Personal UVC Air Disinfector is completely portable wherever you go, runs on a 4-hour rechargeable battery and is designed for powerful air disinfection in cars and for personal spaces up to 100 square feet.
- nUVo™ TOWER, Virus-Targeted Portable UVC Air Disinfector is designed for powerful air disinfection in larger spaces up to 500 square feet.
Free shipping of nUVo™ TRAVELER and nUVo™ TOWER is available within the contiguous United States and interest-free Buy Now Pay Later (BNPL) payment plans through Klarna are available for qualified buyers when purchased directly at nUVo.us.
“As people and countries worldwide continue to battle SARS-CoV-2 and its unpredictable mutations and constantly evolving variants, we believe our patent-pending nUVo™ TRAVELER and nUVo™ TOWER provide uniquely powerful, filter-free and chemical-free air disinfection solutions to help create safer spaces—whether at home, in the office or as they travel,” said James Tu, Chairman and CEO of Energy Focus. “Energy Focus has a long history of proven quality, reliability and success in providing healthy lighting for mission critical facilities such as the US Navy, National Institutes of Health and many other leading healthcare, government and educational institutions, and we are honored and excited to leverage our technology and innovation to bring consumers as well as public and private organizations these groundbreaking and timely biosecurity products to make life safer, freer and more enjoyable as the world strives towards the new normal.”
About Energy Focus, Inc.
Energy Focus is an industry-leading innovator of sustainable LED lighting and lighting control technologies, as well as UVC Disinfector (“UV™ by Energy Focus”) solutions. As the creator of the first flicker-free LED lamps, Energy Focus develops high quality LED lighting products and controls that provide extensive energy and maintenance savings, as well as aesthetics, safety, health and sustainability benefits over conventional lighting. The new EnFocus™ Circadian Lighting System enables existing and new, commercial and residential buildings to provide quality, convenient and affordable, dimmable, and color-tunable, circadian and human-centric lighting capabilities. In addition, our patent-pending UV™ by Energy Focus technologies and products aim to provide effective, reliable and affordable UV™ by Energy Focus solutions for buildings, facilities and homes.
Energy Focus’ customers include U.S. and U.S. ally navies, U.S. federal, state and local governments, healthcare and educational institutions, as well as Fortune 500 companies. Since 2007, Energy Focus has installed approximately 900,000 lighting products across the U.S. Navy fleet, including tubular LEDs, waterline security lights, explosion-proof globes and berth lights, saving more than five million gallons of fuel and 300,000 man-hours in lighting maintenance annually. Energy Focus is headquartered in Solon, Ohio. For more information, visit our website at www.energyfocus.com.
Forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements can generally be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “feels,” “seeks,” “forecasts,” “projects,” “intends,” “plans,” “may,” “will,” “should,” “could” or “would” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our results of operations, financial condition, liquidity, prospects, growth, strategies, capital expenditures, and the industry in which we operate. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Although we base these forward-looking statements on assumptions that we believe are reasonable when made in light of the information currently available to us, we caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and industry developments may differ materially from statements made in or suggested by the forward-looking statements contained in this release. We believe that important factors that could cause our actual results to differ materially from forward-looking statements include, but are not limited to: (i) instability in the U.S. and global economies and business interruptions experienced by us, our customers and our suppliers as a result of the COVID-19 pandemic and related impacts on travel, trade and business operations; (ii) our ability to realize the expected novelty, disinfection effectiveness, affordability and estimated delivery timing of our UVCD products and their appeal compared to other products; (iii) our ability to extend our product portfolio into commercial services and consumer products; (iv) market acceptance of our LED lighting, control and UVCD technologies, services and products; (v) our need for additional financing in the near term to continue our operations; (vi) our ability to refinance or extend maturing debt on acceptable terms or at all; (vii) our ability to continue as a going concern for a reasonable period of time; (viii) our ability to implement plans to increase sales and control expenses; (ix) our reliance on a limited number of customers for a significant portion of our revenue, and our ability to maintain or grow such sales levels; (x) our ability to add new customers to reduce customer concentration; (xi) our reliance on a limited number of third-party suppliers and research and development partners, our ability to manage third-party product development and obtain critical components and finished products from such suppliers on acceptable terms and of acceptable quality despite ongoing global supply chain challenges, and the impact of our fluctuating demand on the stability of such suppliers; (xii) our ability to timely, efficiently and cost-effectively transport products from our third-party suppliers to our facility by ocean marine and other logistics channels despite global supply chain and logistics disruptions; (xiii) our ability to increase demand in our targeted markets and to manage sales cycles that are difficult to predict and may span several quarters; (xiv) the timing of large customer orders, significant expenses and fluctuations between demand and capacity as we invest in growth opportunities; (xv) our ability to compete effectively against companies with lower prices or cost structures, greater resources, or more rapid development capabilities, and new competitors in our target markets; (xvi) our ability to successfully scale our network of sales representatives, agents, distributors and other channel partners to match the sales reach of larger, established competitors; (xvii) our ability to attract, develop and retain qualified personnel, and to do so in a timely manner; (xviii) the impact of any type of legal inquiry, claim or dispute; (xix) the inflationary or deflationary general economic conditions in the United States and in other markets in which we operate or secure products, which could affect our ability to obtain raw materials, component parts, freight, energy, labor, and sourced finished goods in a timely and cost-effective manner; (xx) our dependence on military maritime customers and on the levels and timing of government funding available to such customers, as well as the funding resources of our other customers in the public sector and commercial markets; (xxi) business interruptions resulting from geopolitical actions, including war and terrorism, natural disasters, including earthquakes, typhoons, floods and fires, or from health epidemics, or pandemics or other contagious outbreaks; (xxii) our ability to respond to new lighting technologies and market trends; (xxiii) our ability to fulfill our warranty obligations with safe and reliable products; (xxiv) any delays we may encounter in making new products available or fulfilling customer specifications; (xxv) any flaws or defects in our products or in the manner in which they are used or installed; (xxvi) our ability to protect our intellectual property rights and other confidential information, and manage infringement claims made by others; (xxvii) our compliance with government contracting laws and regulations, through both direct and indirect sale channels, as well as other laws, such as those relating to the environment and health and safety; (xxviii) risks inherent in international markets, such as economic and political uncertainty, changing regulatory and tax requirements and currency fluctuations, including tariffs and other potential barriers to international trade; (xxix) our ability to maintain effective internal controls and otherwise comply with our obligations as a public company; and (xxx) our ability to maintain compliance with the continued listing standards of The Nasdaq Stock Market. For additional factors that could cause our actual results to differ materially from the forward-looking statements, please refer to our most recent annual report on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211208005120/en/
Energy Focus Launches nUVo™ Virus-Targeted UVC Air Disinfectors to Public – Patent-Pending Technologies Designed to Intercept and Destroy 99.9%+ of Airborne Pathogens Including SARS-CoV-2 and its Variants -